Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Jun;25(6):1066–1074. doi: 10.3201/eid2506.181035

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.

PMC Copyright notice

Exposure history and case-fatality rate among patients with laboratory-confirmed Lassa fever cases, Nigeria, January 1–May 6, 2018. A) Proportion of persons reporting Lassa fever exposure risks for all case-patients, HCWs, and non–HCWs. To assess differences in exposure risks between HCWs and non–HCWs, p values were calculated by using the χ² test and adjusted by the Bonferroni correction. B) The case-fatality rate for case-patients who did or did not receive ribavirin. C) An investigation of the case-fatality rate in patients who survived >7 days after symptom onset. For panels B and C, p values were calculated by using binomial logistic regression analysis adjusted for age and sex and applying the Bonferroni correction. HCW, healthcare worker.